(Q38223328)

English

HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.

scientific article published on September 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

0 references

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Phillip Chan

1

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Bruce J Brew

2

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

publication date

1 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Current HIV/AIDS reports

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

317-324

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

https://scigraph.springernature.com/pub.10.1007/s11904-014-0221-0

0 references

Neurological complications of HIV infection.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

The prevalence and incidence of neurocognitive impairment in the HAART era.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Neuropsychologic impairment in early HIV infection. A risk factor for work disability.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Paradoxes of adherence and drug resistance to HIV antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Mild cognitive impairment and risk of mortality in HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Parkinsonism in hiv-infected patients on highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Autophagy is increased in postmortem brains of persons with HIV-1-associated encephalitis

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Disruption of neuronal autophagy by infected microglia results in neurodegeneration

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Altered proteasomal function in sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Persistent hijacking of brain proteasomes in HIV-associated dementia

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Effects of APOE ε4, age, and HIV on glial metabolites and cognitive deficits

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

The influence of HLA on HIV-associated neurocognitive impairment in Anhui, China

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Diffusion Tensor Imaging of the Brain

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV+ patients

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Patterns of white matter injury in HIV infection after partial immune reconstitution: a DTI tract-based spatial statistics study

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Frontostriatal fiber bundle compromise in HIV infection without dementia

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

The effects of HIV and combination antiretroviral therapy on white matter integrity

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Greater than age-related changes in brain diffusion of HIV patients after 1 year

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Compromised fronto-striatal functioning in HIV: an fMRI investigation of semantic event sequencing

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Combination antiretroviral therapy modulates the blood oxygen level-dependent amplitude in human immunodeficiency virus-seropositive patients

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Pathways to neurodegeneration: effects of HIV and aging on resting-state functional connectivity

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

HIV-associated neurocognitive disorders: antiretroviral regimen, central nervous system penetration effectiveness, and cognitive outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Factors in AIDS dementia complex trial design: results and lessons from the abacavir trial

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Cytochrome C dysregulation induced by HIV infection of astrocytes results in bystander apoptosis of uninfected astrocytes by an IP3 and calcium-dependent mechanism

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Molecular and pathologic insights from latent HIV-1 infection in the human brain

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Lost in translation: again, another failed neuroprotection trial.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

An active lifestyle is associated with better neurocognitive functioning in adults living with HIV infection.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Higher CNS Penetration-Effectiveness of Long-term Combination Antiretroviral Therapy Is Associated With Better HIV-1 Viral Suppression in Cerebrospinal Fluid

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0221-0

21 January 2018

Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffusion alterations in corpus callosum of patients with HIV.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The HIV Dementia Scale: predictive power in mild dementia and HAART

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV Dementia Scale: a rapid screening test.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffusion-tensor MR imaging of the brain in human immunodeficiency virus-positive patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complex.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central nervous system antiretroviral penetration and cognitive functioning in largely pretreated HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Should antiretroviral therapy for HIV infection be tailored for intracerebral penetration?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

gp120-induced alterations of human astrocyte function: Na(+)/H(+) exchange, K(+) conductance, and glutamate flux

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV protease inhibitor exposure predicts cerebral small vessel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24966139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11904-014-0221-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24966139%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38223328&oldid=1510296496"